Renda Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer, Lipids, and Metabolism 4
-
- Lung Cancer Diagnosis and Treatment 5
- Ferroptosis and cancer prognosis 3
- Metastasis and carcinoma case studies 3
- Co-authors
- Yibo Gao (14 shared papers)Wei Guo (8 shared papers)Fei Shao (6 shared papers)Zhenlin Yang (9 shared papers)Jie He (7 shared papers)Fengwei Tan (10 shared papers)Jie He (5 shared papers)Shugeng Gao (7 shared papers)
- Journals
- Cancer Medicine (2 papers)Frontiers in Oncology (2 papers)Journal of Thoracic and Cardiovascular Surgery (2 papers)Molecular Pharmaceutics (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Renda Li
31 papers receiving 806 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 252
- Oncology 213
- Pulmonary and Respiratory Medicine 223
- Molecular Biology 356
- Immunology 79
Countries citing papers authored by Renda Li
This map shows the geographic impact of Renda Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renda Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renda Li more than expected).
Fields of papers citing papers by Renda Li
This network shows the impact of papers produced by Renda Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renda Li. The network helps show where Renda Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Renda Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 130 | |
| 2 | 2020 | 93 | |
| 3 | 2021 | 73 | |
| 4 | 2017 | 64 | |
| 5 | 2022 | 59 | |
| 6 | 2020 | 52 | |
| 7 | 2022 | 43 | |
| 8 | 2021 | 36 | |
| 9 | 2019 | 27 | |
| 10 | 2021 | 24 | |
| 11 | 2020 | 22 | |
| 12 | 2020 | 20 | |
| 13 | 2023 | 19 | |
| 14 | 2022 | 19 | |
| 15 | 2023 | 19 | |
| 16 | 2024 | 18 | |
| 17 | 2021 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2023 | 16 | |
| 20 | 2022 | 10 |
About Renda Li
Renda Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Surgery, having authored 32 papers that have together received 817 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), RNA modifications and cancer (4 papers), Cancer, Lipids, and Metabolism (4 papers), Ferroptosis and cancer prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Peptidase Inhibition and Analysis (3 papers), Metastasis and carcinoma case studies (3 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (252 citations), Oncology (213 citations), Pulmonary and Respiratory Medicine (223 citations), Molecular Biology (356 citations) and Immunology (79 citations). Renda Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yibo Gao, Wei Guo, Fei Shao, Zhenlin Yang, Jie He, Fengwei Tan, Jie He, Shugeng Gao, Sijin Sun and Hao Zhang. Their work appears in journals such as Cancer Medicine, Frontiers in Oncology, Journal of Thoracic and Cardiovascular Surgery, Molecular Pharmaceutics and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.